Warning letterPosted December 18, 2025
FDA warning letter to Flux Lab Pte. Ltd. d/b/a The Fluxion
Failure to Register and List/Misbranded
FDA posted a warning letter to Flux Lab Pte. Ltd. d/b/a The Fluxion on December 18, 2025; the letter is dated December 16, 2025. Subject: Failure to Register and List/Misbranded. Issuing office: Center for Devices and Radiological Health.
On the record
- Company
- Flux Lab Pte. Ltd. d/b/a The Fluxion
- Subject
- Failure to Register and List/Misbranded
- Issuing office
- Center for Devices and Radiological Health
- Letter dated
- 2025-12-16
- Posted by FDA
- 2025-12-18
- Source
- FDA warning letters ↗
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch Flux Lab Pte. Ltd. d/b/a The Fluxion
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Flux Lab Pte. Ltd. d/b/a The Fluxion.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.